TABLE 2.
Detection of infectivity in cervical trunks of the vagus nerve by bioassaysa
Donor | Vagus nerve sample | Incubation time (days)
|
Estimated titer (ID50i.c./sample)b | |
---|---|---|---|---|
Range | Mean ± SE | |||
S1 | Left | 119–292 | 162 ± 30 | 101.3 |
Right | 117–155 | 126 ± 7 | 102.7 | |
S2 | Left | 117–239 | 144 ± 22 | 101.8 |
Right | 117–180 | 134 ± 11 | 102.3 | |
S3 | Left | 120–260 | 151 ± 25 | 101.6 |
Right | 131–222 | 167 ± 18 | 101.3 | |
S4 | Left | 131–183 | 159 ± 10 | 101.5 |
Right | 127–152 | 139 ± 4 | 102.0 | |
S5 | Left | 124–242 | 153 ± 20 | 101.6 |
Right | 145–274 | 190 ± 21 | <101.2 |
Aliquots (50 μl) of homogenized left and right vagus nerves from terminally ill hamsters orally challenged with 263K were inoculated i.c. into groups of five recipients. Mortality was 100%. Recipients similarly inoculated with vagus nerves from donors previously orally mock infected with normal brain homogenate showed no clinical signs of scrapie. The experiment was terminated at 370 dpi.
Total amount of infectivity in one equivalent of excised tissue, i.e., the entire donor sample, calculated by applying mean incubation time to a dose-response curve.